SBBP
$2.98
Strongbridge Bio Ord
$.17
6.05%
SBBP
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.13)
Revenue:  $8.89 Mil
Wednesday
Aug 11
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SBBP reports earnings?
Beat
Meet
Miss

Where is SBBP's stock price going from here?
Up
Flat
Down
Stock chart of SBBP
Analysts
Summary of analysts' recommendations for SBBP
Score
Grade
Pivots
Resistance
$2.93
$2.88
$2.85

$2.80

Support
$2.77
$2.72
$2.69
Tweet
Growth
Description
Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing's syndrome, COR-004 and COR-005 to treat acromegaly, BP-2001, the treatment of diabetes which are in different clinical trial. Strongbridge Biopharma PLC is based in Trevose, Pennsylvania.